Fiche centre
The University of Vermont Medical Center
Burlington — United States
Essais liés3clinical trials
VilleBurlingtonlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05839730
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Pacemaker PLR + TRT ON | Insuffisance cardiaque | Non applicable | NCT05839730 | FIRE-HFpEF — Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction | ACTIVE_NOT_RECRUITING |
| Cladribine Low Dose | Myasthénie | Phase 3 | NCT06463587 | Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad) | RECRUITING |
| Rimegepant/BHV3000 | Migraine | Phase 3 | NCT04649242 | Randomized Study in Children and Adolescents With Migraine: Acute Treatment | RECRUITING |